Pharmacological targeting of ion channels for cancer therapy: In vivo evidences

Luigi Leanza1, Antonella Managò1, Mario Zoratti2

  • 1Department of Biology, University of Padua, Padua, Italy.

Insights

Ion channels regulate cell death and proliferation, emerging as key cancer targets. Research shows targeting these channels, including calcium, sodium, and potassium, holds significant therapeutic potential for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biophysics

Background:

  • Ion channels play crucial roles in cell proliferation and programmed cell death.
  • Their dysregulation is frequently observed in tumor cells and tissues, highlighting their oncogenic potential.
  • The field of ion channel research in cancer has rapidly advanced over the past two decades.

Purpose of the Study:

  • To provide an updated overview of ion channel involvement in cancer.
  • To critically discuss preclinical findings on ion channel modulators in cancer models.
  • To highlight challenges and opportunities in targeting ion channels for cancer therapy.

Main Methods:

  • Review of preclinical studies utilizing specific pharmacological modulators of calcium, sodium, potassium, and anion-permeable ion channels.
  • Analysis of in vivo experiments in various cancer models.
  • Discussion of drug repositioning strategies for ion channel modulators.

Main Results:

  • Numerous ion channels (calcium, sodium, potassium, anion-permeable) are implicated in cancer progression.
  • Pharmacological modulation of these channels shows promise in preclinical cancer models.
  • Natural products and repositioned drugs are among the potent therapeutic agents identified.

Conclusions:

  • Ion channels represent promising oncological targets with significant therapeutic potential.
  • Further research is needed to clarify mechanisms and address specificity and side-effect issues.
  • Drug repositioning offers a faster pathway for clinical translation of ion channel-targeted therapies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
9.0K
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
13.0K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.7K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.3K